Taysha Gene Therapies Inc (TSHA): Insights At A Glance
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.67, with 7.89 million shares of worth about $21.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.66% during that period and on June 11, 2025 the price saw […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) Has Another Chance To Impress You
Currently, there are 205.05M common shares owned by the public and among those 176.26M shares have been available to trade. The company’s stock has a 5-day price change of 6.72% and 70.55% over the past three months. TSHA shares are trading 60.69% year to date (YTD), with the 12-month market performance down to -11.18% lower. […]
Investors Should Take Note Of Taysha Gene Therapies Inc (TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.75, with 22.17 million shares of worth about $60.97 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.34% during that period and on May 29, 2025 the price saw […]
Growing Through Challenges? – Taysha Gene Therapies Inc (TSHA)
Currently, there are 205.05M common shares owned by the public and among those 176.26M shares have been available to trade. The company’s stock has a 5-day price change of 25.21% and 78.66% over the past three months. TSHA shares are trading 69.36% year to date (YTD), with the 12-month market performance down to -6.69% lower. […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) – Not A Clear Buying Opportunity?
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.52, with 6.5 million shares of worth about $16.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.25% during that period and on Wednesday the price saw a gain […]
Is Taysha Gene Therapies Inc (NASDAQ: TSHA) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Taysha Gene Therapies Inc (NASDAQ:TSHA). The institutional investor has increased its shareholding in the Healthcare company by 2,035.03% to 24.53 million shares with purchase of 23.38 million shares. This fresh investment now brings its stake to 13.12% valued currently at $43.17 million. […]
Some Investing Thoughts On Taysha Gene Therapies Inc (NASDAQ: TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on December 20, 2023 at a closing price of $1.42, with 5.1 million shares of worth about $7.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 98.46% during that period and On Wednesday the price saw […]